SCHEMBL22928759

SCHEMBL22928759

CC1(C)CCCCN1F

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL765969 0.69
SCHEMBL1008220 0.69
SCHEMBL9282368 0.67
SCHEMBL17423998 0.67 SOS1 (0.33)
SCHEMBL19072213 0.67 SOS1 (0.33)
Ammonia Solution, Strong SCHEMBL17812443 0.67 SOS1 (0.33)
SCHEMBL22930557 0.67 SOS1 (0.33)
SCHEMBL22442265 0.67
SCHEMBL9736941 0.67
SCHEMBL8464116 0.67 SOS1 (0.33)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240140957-A1 BRIDGED COMPOUNDS AS KRAS G12D INHIBITOR AND DEGRADER AND THE USE THEREOF BEONE MEDICINES I GMBH (CH) 2024-05-02 US disclosed
EP-3380101-B1 EIF4-A-INHIBITING COMPOUNDS AND METHODS RELATED THERETO EFFECTOR THERAPEUTICS INC (US) 2021-01-27 EP disclosed